744 related articles for article (PubMed ID: 27892767)
1. Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation.
Amodio N; D'Aquila P; Passarino G; Tassone P; Bellizzi D
Expert Opin Ther Targets; 2017 Jan; 21(1):91-101. PubMed ID: 27892767
[TBL] [Abstract][Full Text] [Related]
2. Role of epigenetics-microRNA axis in drug resistance of multiple myeloma.
Rastgoo N; Abdi J; Hou J; Chang H
J Hematol Oncol; 2017 Jun; 10(1):121. PubMed ID: 28623912
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the Epigenetic Symphony of Cancer: Insights and Epigenetic Therapies Implications.
Akram F; Tanveer R; Andleeb S; Shah FI; Ahmad T; Shehzadi S; Akhtar AM; Syed G
Technol Cancer Res Treat; 2024; 23():15330338241250317. PubMed ID: 38780251
[TBL] [Abstract][Full Text] [Related]
4. Laboratory methods to decipher epigenetic signatures: a comparative review.
Halabian R; Valizadeh Arshad ; Ahmadi A; Saeedi P; Azimzadeh Jamalkandi S; Alivand MR
Cell Mol Biol Lett; 2021 Nov; 26(1):46. PubMed ID: 34763654
[TBL] [Abstract][Full Text] [Related]
5. Targeting Epigenetic Regulators for Endometrial Cancer Therapy: Its Molecular Biology and Potential Clinical Applications.
Inoue F; Sone K; Toyohara Y; Takahashi Y; Kukita A; Hara A; Taguchi A; Tanikawa M; Tsuruga T; Osuga Y
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669072
[TBL] [Abstract][Full Text] [Related]
6. An Overview of Epigenetic Changes in the Parkinson's Disease Brain.
Klokkaris A; Migdalska-Richards A
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892355
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modifications in cancer.
Kanwal R; Gupta S
Clin Genet; 2012 Apr; 81(4):303-11. PubMed ID: 22082348
[TBL] [Abstract][Full Text] [Related]
8. The roles of epigenetic regulation in graft-versus-host disease.
Wang Y; Liu Q; Deng L; Ma X; Gong Y; Wang Y; Zhou F
Biomed Pharmacother; 2024 Jun; 175():116652. PubMed ID: 38692061
[TBL] [Abstract][Full Text] [Related]
9. The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma.
Pawlyn C; Kaiser MF; Heuck C; Melchor L; Wardell CP; Murison A; Chavan SS; Johnson DC; Begum DB; Dahir NM; Proszek PZ; Cairns DA; Boyle EM; Jones JR; Cook G; Drayson MT; Owen RG; Gregory WM; Jackson GH; Barlogie B; Davies FE; Walker BA; Morgan GJ
Clin Cancer Res; 2016 Dec; 22(23):5783-5794. PubMed ID: 27235425
[TBL] [Abstract][Full Text] [Related]
10. The landscape of alterations affecting epigenetic regulators in T-cell acute lymphoblastic leukemia: Roles in leukemogenesis and therapeutic opportunities.
Walia Y; de Bock CE; Huang Y
Int J Cancer; 2024 May; 154(9):1522-1536. PubMed ID: 38155420
[TBL] [Abstract][Full Text] [Related]
11. Ferroptosis Induction in Multiple Myeloma Cells Triggers DNA Methylation and Histone Modification Changes Associated with Cellular Senescence.
Logie E; Van Puyvelde B; Cuypers B; Schepers A; Berghmans H; Verdonck J; Laukens K; Godderis L; Dhaenens M; Deforce D; Vanden Berghe W
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830117
[TBL] [Abstract][Full Text] [Related]
12. Deciphering epigenetic regulations in the inflammatory pathways of atopic dermatitis.
da Silva Duarte AJ; Sanabani SS
Life Sci; 2024 Jul; 348():122713. PubMed ID: 38735367
[TBL] [Abstract][Full Text] [Related]
13. The DNA methylation landscape of hematological malignancies: an update.
Blecua P; Martinez-Verbo L; Esteller M
Mol Oncol; 2020 Aug; 14(8):1616-1639. PubMed ID: 32526054
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic modifications by dietary phytochemicals: implications for personalized nutrition.
Shankar S; Kumar D; Srivastava RK
Pharmacol Ther; 2013 Apr; 138(1):1-17. PubMed ID: 23159372
[TBL] [Abstract][Full Text] [Related]
15. Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.
Desaulniers D; Vasseur P; Jacobs A; Aguila MC; Ertych N; Jacobs MN
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681626
[TBL] [Abstract][Full Text] [Related]
16. Noncoding RNA as an influential epigenetic modulator with promising roles in cancer therapeutics.
Roy L; Chatterjee O; Bose D; Roy A; Chatterjee S
Drug Discov Today; 2023 Sep; 28(9):103690. PubMed ID: 37379906
[TBL] [Abstract][Full Text] [Related]
17. Nucleic acid and protein methylation modification in renal diseases.
Jin J; Liu XM; Shao W; Meng XM
Acta Pharmacol Sin; 2024 Apr; 45(4):661-673. PubMed ID: 38102221
[TBL] [Abstract][Full Text] [Related]
18. Beyond genetics: Exploring the role of epigenetic alterations in breast cancer.
Prabhu KS; Sadida HQ; Kuttikrishnan S; Junejo K; Bhat AA; Uddin S
Pathol Res Pract; 2024 Feb; 254():155174. PubMed ID: 38306863
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic roles in the malignant transformation of gastric mucosal cells.
Tie J; Zhang X; Fan D
Cell Mol Life Sci; 2016 Dec; 73(24):4599-4610. PubMed ID: 27464701
[TBL] [Abstract][Full Text] [Related]
20. Epigenomic alterations in cancer: mechanisms and therapeutic potential.
Gray JS; Wani SA; Campbell MJ
Clin Sci (Lond); 2022 Apr; 136(7):473-492. PubMed ID: 35383835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
